TEFAF Oncology Chair
General information TEFAF Oncology Chair
There are new fields in which the further development of medical techniques and expertise is more pressing than in the field of Oncology. Therefore, the Board of Management of University Hospital Maastricht and the Faculty of Health, Medicine and Life Sciences are especially grateful to TEFAF Maastricht for its initiative to support medical cancer research.
The TEFAF Oncology Chair is initially installed for the duration of five years with possible prolongation.
Composition of the Supervisory Council
- President of TEFAF
- Scientific Director of GROW
- Dean of the Faculty of Health, Medicine and Life Sciences Maastricht University
- President of the Board of Directors of University Hospital Maastricht
- Former governor of the "Provincie Limburg" (Baron van Voorst tot Voorst)
The Supervisory Council has been formed to guide the selection procedure for this TEFAF Oncology chair and to perform an evaluation on a yearly basis.
topProgram TEFAF Oncology Chair
Program 2009
In December 2008, Prof. Catherine Verfaillie (Katholieke Universiteit Leuven, Belgium) was appointed as third TEFAF visiting professor:
Prof. Catherine Verfaillie is an internationally recognised expert in the field of stem cell biology of cancer, but also of other diseases. She is director of the interdepartmental stem cell institute at the Katholieke Universiteit Leuven and is professor of Oncology and Hematology at the University Hospitals Leuven. From 1999 to 2007 she was director of the stem cell institute at the University of Minnesota.
Planned events 2009
Former visiting professors
The first TEFAF visiting professor (2005-2006) was Prof. James G. Herman, MD, PhD (Johns Hopkins, Baltimore, USA).
The second TEFAF visiting professor (2007-2008) was Prof. Robert J. Gillies (Moffitt Cancer Center, Tampa, USA).